Here's What We Like About Dr. Lal PathLabs' (NSE:LALPATHLAB) Upcoming Dividend

It looks like Dr. Lal PathLabs Limited (NSE:LALPATHLAB) is about to go ex-dividend in the next 3 days. The ex-dividend date generally occurs two days before the record date, which is the day on which shareholders need to be on the company's books in order to receive a dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Therefore, if you purchase Dr. Lal PathLabs' shares on or after the 11th of November, you won't be eligible to receive the dividend, when it is paid on the 4th of December.

The company's next dividend payment will be ₹5.00 per share, and in the last 12 months, the company paid a total of ₹20.00 per share. Looking at the last 12 months of distributions, Dr. Lal PathLabs has a trailing yield of approximately 1.0% on its current stock price of ₹1970.00. We love seeing companies pay a dividend, but it's also important to be sure that laying the golden eggs isn't going to kill our golden goose! As a result, readers should always check whether Dr. Lal PathLabs has been able to grow its dividends, or if the dividend might be cut.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. Dr. Lal PathLabs is paying out an acceptable 50% of its profit, a common payout level among most companies. A useful secondary check can be to evaluate whether Dr. Lal PathLabs generated enough free cash flow to afford its dividend. Fortunately, it paid out only 43% of its free cash flow in the past year.

It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.

Check out our latest analysis for Dr. Lal PathLabs

Click here to see the company's payout ratio, plus analyst estimates of its future dividends.

Have Earnings And Dividends Been Growing?

Companies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. Fortunately for readers, Dr. Lal PathLabs's earnings per share have been growing at 15% a year for the past five years. Dr. Lal PathLabs has an average payout ratio which suggests a balance between growing earnings and rewarding shareholders. Given the quick rate of earnings per share growth and current level of payout, there may be a chance of further dividend increases in the future.

The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Dr. Lal PathLabs has delivered 32% dividend growth per year on average over the past 10 years. Both per-share earnings and dividends have both been growing rapidly in recent times, which is great to see.

To Sum It Up

Has Dr. Lal PathLabs got what it takes to maintain its dividend payments? Dr. Lal PathLabs's growing earnings per share and conservative payout ratios make for a decent combination. We also like that it paid out a lower percentage of its cash flow. Overall we think this is an attractive combination and worthy of further research.

With that in mind, a critical part of thorough stock research is being aware of any risks that stock currently faces. For example - Dr. Lal PathLabs has 1 warning sign we think you should be aware of.

Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.